ZyVersa Therapeutics, Inc.

NasdaqCM:ZVSA Voorraadrapport

Marktkapitalisatie: US$2.1m

ZyVersa Therapeutics Beheer

Beheer criteriumcontroles 1/4

ZyVersa Therapeutics' CEO is Steve Glover, appointed in Dec 2022, has a tenure of 1.92 years. total yearly compensation is $993.22K, comprised of 55.4% salary and 44.6% bonuses, including company stock and options. directly owns 0.13% of the company’s shares, worth $2.74K. The average tenure of the management team and the board of directors is 1.9 years and 1.9 years respectively.

Belangrijke informatie

Steve Glover

Algemeen directeur

US$993.2k

Totale compensatie

Percentage CEO-salaris55.4%
Dienstverband CEO1.9yrs
Eigendom CEO0.1%
Management gemiddelde ambtstermijn1.9yrs
Gemiddelde ambtstermijn bestuur1.9yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Steve Glover's beloning veranderd ten opzichte van ZyVersa Therapeutics's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$22m

Mar 31 2024n/an/a

-US$106m

Dec 31 2023US$993kUS$550k

-US$106m

Sep 30 2023n/an/a

-US$88m

Jun 30 2023n/an/a

-US$98m

Mar 31 2023n/an/a

-US$14m

Dec 31 2022US$1mUS$451k

-US$14m

Sep 30 2022n/an/a

-US$21m

Jun 30 2022n/an/a

-US$10m

Mar 31 2022n/an/a

-US$10m

Dec 31 2021US$2mUS$451k

-US$8m

Dec 31 2020US$451kUS$451k

-US$13m

Compensatie versus markt: Steve's total compensation ($USD993.22K) is above average for companies of similar size in the US market ($USD655.65K).

Compensatie versus inkomsten: Steve's compensation has been consistent with company performance over the past year.


CEO

Steve Glover (64 yo)

1.9yrs

Tenure

US$993,217

Compensatie

Mr. Stephen C. Glover, also known as Steve, serves as Chairman of the Board at Ambrx Biopharma Inc. since May 18, 2023. He has been a Director of Incon Co., Ltd. since December 2018.Mr. Glover is a Co-Fou...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Stephen Glover
Co-Founder1.9yrsUS$993.22k0.13%
$ 2.7k
Peter Wolfe
CFO & Secretary1.9yrsUS$573.36k0.012%
$ 244.6
Karen Cashmere
Chief Commercial Officer1.9yrsUS$486.69k0%
$ 0
Melda Uzbil O'connell
Senior Vice President of Corporate Developmentno datageen gegevensgeen gegevens
Pablo Guzman
Chief Medical Officer1.8yrsgeen gegevens0.0071%
$ 145.3

1.9yrs

Gemiddelde duur

68yo

Gemiddelde leeftijd

Ervaren management: ZVSA's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Bestuursleden

NaamPositieTenureCompensatieEigendom
Stephen Glover
Co-Founder1.9yrsUS$993.22k0.13%
$ 2.7k
Pablo Guzman
Chief Medical Officerno datageen gegevens0.0071%
$ 145.3
Gregory Freitag
Independent Director1.8yrsUS$80.14k0%
$ 0
Robert Finizio
Independent Director1.9yrsUS$80.64k0%
$ 0
James Sapirstein
Independent Director1.8yrsUS$72.90k0%
$ 0
Marlene Haffner
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Alessia Fornoni
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Helen Bramlett
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Juan de Rivero Vaccari
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Robert Keane
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Sharon Adler
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Min-Chul Park
Independent Director1.9yrsUS$66.39k0%
$ 0

1.9yrs

Gemiddelde duur

63yo

Gemiddelde leeftijd

Ervaren bestuur: ZVSA's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.